Thammasat University Hospital
Pathum Thani, Changwat Pathum Thani, 12120, Thailand
NCT Number: NCT05447364
The purpose of this study is to compare the efficacy of 75 mg of Pregabalin and 150 mg of Pregabalin in postoperative pain control after TKA.
Looking for future studies?
Notify Me55 year–80 year
All sexes
Interventional
Phase 4
Pathum Thani, Changwat Pathum Thani, 12120, Thailand
After being informed about the study and potential risks, all patients giving written informed consent will be chosen for eligibility for the study entry. At the day before surgery date, patients who meet the eligibility criteria will be randomized in a double-blind manner (participant and investigator) in a 1:1 ratio to 75 mg of Pregabalin and 150 mg of Pregabalin groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 tab of Pregabalin Brillior 75 mg and 1 tab of Placebo
2 tabs of Pregabalin Brillior 75 mg
Time frame: 6, 12, 18, 24, 48 hours & 2, 6, 12 weeks after surgery
Time frame: From postoperative period until 48 hours after surgery
Amount of Morphine consumption as rescue pain control reported as mg per day
Time frame: 6, 12, 18, 24, 48 hours & 2, 6, 12 weeks after surgery
Common of side effects of Pregabalin and Morphine including sedation, dizziness, visual disturbances, nausea and vomiting
Time frame: From postoperative period until 48 hours after surgery
Time to discharge
Time frame: From postoperative period until 48 hours after surgery
Time from operation to ambulation before hospital discharge
Time frame: 2, 6, 12 weeks after surgery
Time frame: 2, 6, 12 weeks after surgery
Time frame: 2, 6, 12 weeks after surgery
Time frame: 2, 6, 12 weeks after surgery
Time frame: 2, 6, 12 weeks after surgery
Thammasat University
Other
Efficacy of Different Doses of Pregabalin as a Multimodal Analgesic Agent in Postoperative Pain Control After Total Knee Arthroplasty - A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07327190
Arthritis, Joint Diseases
Kütahya, Turkey (Türkiye)
View Trial DetailsNCT04492670
Arthritis, Joint Diseases
Hong Kong
View Trial DetailsNCT04653896
Arthritis, Joint Diseases
The Bronx, New York, United States
View Trial DetailsNCT07717957
Arthritis, Joint Diseases
Kuantan, Pahang, Malaysia
View Trial Details